This "Ask Me Anything" recording provides expert perspectives on the current and future state of hemophilia gene therapy, including lessons from clinical implementation, emerging innovations, and evolving treatment paradigms in North America.
This education is supported by independent educational grants from BioMarin, CSL Behring, and Pfizer.
